Worth Seeing!
Transform your wealth with Omega. Exclusive consultation awaits. Schedule Meeting! Schedule Meeting!
mw4me logo
Talk to Us | Subscribe | Advisory Services
Buy Alpha stocks

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 81332.72
1292.92 (1.62%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on Jul-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Medicamen Biotech Ltd.
572
(Small Cap)
449.70
(-0.43%)
43.18
2.84
4.34
7.42
Q V PT
2
Panacea Biotec Ltd.
843
(Small Cap)
138.65
(1.35%)
236.03
2.55
-14.85
0.00
Q V PT
3
Bajaj Healthcare Ltd.
1,017
(Small Cap)
362
(-1.79%)
N/A
3.65
18.39
25.96
Q V+ PT
4
Sastasundar Ventures Ltd.
993
(Small Cap)
314
(0.58%)
N/A
3.64
-100.00
-43.78
Q V PT
5
Jagsonpal Pharmaceuticals Ltd.
1,041
(Small Cap)
397.20
(3.99%)
44.99
5.39
13.35
0.00
Q V+ PT
6
Vimta Labs Ltd.
1,219
(Small Cap)
552.50
(0.80%)
31.3
3.78
8.03
8.93
Q V+ PT
7
Bliss GVS Pharma Ltd.
1,245
(Small Cap)
118.30
(-0.76%)
20
1.25
7.25
4.05
Q V PT
8
Kopran Ltd.
1,250
(Small Cap)
259.30
(0.37%)
35.96
2.99
12.18
217.28
Q V+ PT
9
Lincoln Pharmaceuticals Ltd.
1,306
(Small Cap)
650.30
(1.28%)
13.78
2.17
9.45
16.46
Q V+ PT
10
KMC Speciality Hospitals (India) Ltd.
1,371
(Small Cap)
83.75
(1.70%)
N/A
N/A
17.12
31.95
Q V PT
11
Syncom Formulations (India) Ltd.
1,428
(Small Cap)
15.19
(-0.91%)
61
5.03
7.21
10.35
Q V+ PT
12
NGL Fine-Chem Ltd.
1,636
(Small Cap)
2,667.40
(2.73%)
41.64
6.1
19.33
11.86
Q V+ PT
13
Sigachi Industries Ltd.
2,164
(Small Cap)
66.97
(1.56%)
52.77
5.27
23.28
32.58
Q V+ PT
14
Krsnaa Diagnostics Ltd.
2,176
(Small Cap)
693.85
(2.98%)
38.28
2.69
0.00
0.00
Q V PT
15
Themis Medicare Ltd.
2,277
(Small Cap)
247.35
(-0.52%)
92.48
7.6
15.70
0.00
Q V+ PT
16
SMS Pharmaceuticals Ltd.
2,343
(Small Cap)
280.05
(1.19%)
47.4
4.11
2.34
-48.56
Q V+ PT
17
IOL Chemicals And Pharmaceuticals Ltd.
2,429
(Small Cap)
413
(0.05%)
18.03
1.5
0.00
0.00
Q V+ PT
18
Indraprastha Medical Corporation Ltd.
2,484
(Small Cap)
272.55
(1.04%)
19.95
5.18
7.86
31.45
Q V+ PT
19
Dishman Carbogen Amcis Ltd.
2,650
(Small Cap)
168.20
(-0.47%)
N/A
0.47
7.32
-23.69
Q V+ PT
20
Hester Biosciences Ltd.
2,728
(Small Cap)
3,220
(4.11%)
96.87
8.41
13.51
0.65
Q V+ PT
21
Tarsons Products Ltd.
2,729
(Small Cap)
515
(0.39%)
53.26
4.4
0.00
0.00
Q V PT
22
Novartis India Ltd.
2,854
(Small Cap)
1,156
(1.56%)
32.99
3.77
-7.35
20.51
Q V+ PT
23
Solara Active Pharma Sciences Ltd.
2,904
(Small Cap)
619.80
(2.45%)
N/A
2.12
22.61
-221.22
Q V PT
24
Morepen Laboratories Ltd.
2,977
(Small Cap)
58.23
(1.23%)
26.5
3.31
19.01
9.18
Q V PT
25
Indoco Remedies Ltd.
2,983
(Small Cap)
324.15
(0.02%)
28.28
2.62
9.93
28.74
Q V+ PT
26
Shalby Ltd.
2,995
(Small Cap)
279.55
(0.83%)
27.69
2.74
13.24
14.33
Q V PT
27
Supriya Lifescience Ltd.
3,075
(Small Cap)
387.90
(1.52%)
25.82
3.77
16.71
67.00
Q V PT
28
RPG Life Sciences Ltd.
3,263
(Small Cap)
1,930.95
(-2.14%)
35.35
8.13
12.01
53.20
Q V+ PT
29
Suven Life Sciences Ltd.
3,233
(Small Cap)
148.25
(4.99%)
N/A
3.64
-47.23
-178.05
Q V PT
30
Artemis Medicare Services Ltd.
3,219
(Small Cap)
249
(6.43%)
65.5
8.53
9.11
0.00
Q V+ PT
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Artemis Medicare
2496.43%
Divis Lab
4,792.155.33%
Cipla
1,578.255.22%
Suven Life Sciences
148.254.99%
Apollo Hospital Ent.
6,665.154.33%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Guj. Themis Biosyn
483.75-3.91%
Mankind Pharma
2,065.10-3.68%
Innova Captab
610.25-2.57%
RPG Life Sciences
1,930.95-2.14%
Kovai Medical Center
4,225.30-1.88%
View More

News about Top Pharma Companies in India

Hester Biosciences informs about AGM and annual report

Pursuant to regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’), Hester Biosciences has submitted the Annual Report of the Company along with the Notice of the 37th Annual General Meeting (‘AGM’) for the financial year 2023-24, which has been sent to the members of the Company through electronic means as per the circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India (‘SEBI’). Details with regard to AGM are enclosed.

The above information is a part of company’s filings submitted to BSE.

26 Jul, 2024

Kopran informs about issuance of duplicated share certificate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 as amended, Kopran has informed that Bigshare Services, the Registrar and Share Transfer Agent of the Company has issued duplicate share certificates of the Company, in lieu of the lost/misplaced original share certificates as per the details enclosed.

The above information is a part of company’s filings submitted to BSE.

26 Jul, 2024

Indoco Remedies informs about disclosure

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023, Indoco Remedies has informed that it enclosed in Annexure A the details of the Order received against appeal filed under Section 107 from the Goods and Service Tax (GST) Authority. Based on the advice of its advisors, Company will be filing appropriate response to the said Order within the prescribed timelines.

The above information is a part of company’s filings submitted to BSE.




26 Jul, 2024

Indoco Remedies informs about press release

Pursuant to the Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Indoco Remedies has informed that it enclosed copies of the newspaper advertisement published today, 24th July, 2024 in Business Standard (All India Editions) (English Newspaper) and Mumbai Lakshadeep (Marathi Newspaper) with respect to the extract of Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30th June, 2024.

The above information is a part of company’s filings submitted to BSE.

24 Jul, 2024

Bliss GVS Pharma - Quaterly Results

The sales figure stood at Rs. 1489.63 millions for the June 2024 quarter. The mentioned figure indicates a growth of about 36.67% as compared to Rs. 1089.92 millions during the year-ago period.Net Profit witnessed a 159.08% growth almost the double from Rs. 74.96 millions to Rs. 194.21  millions  of same quarter last year.Operating profit for the quarter ended June 2024 rose to 335.83 millions as compared to 175.78 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1489.63 1089.92 36.67 1489.63 1089.92 36.67 6054.60 5983.40 1.19
Other Income 68.41 65.27 4.81 68.41 65.27 4.81 335.01 507.66 -34.01
PBIDT 335.83 175.78 91.05 335.83 175.78 91.05 1406.68 1409.21 -0.18
Interest 11.68 13.09 -10.77 11.68 13.09 -10.77 58.06 100.56 -42.26
PBDT 324.15 162.69 99.24 324.15 162.69 99.24 937.76 1308.65 -28.34
Depreciation 62.61 53.64 16.72 62.61 53.64 16.72 235.19 151.73 55.01
PBT 261.54 109.05 139.83 261.54 109.05 139.83 702.57 1156.92 -39.27
TAX 67.33 34.09 97.51 67.33 34.09 97.51 196.13 302.14 -35.09
Deferred Tax -2.95 7.00 -142.14 -2.95 7.00 -142.14 -75.49 -42.10 79.31
PAT 194.21 74.96 159.08 194.21 74.96 159.08 506.44 854.78 -40.75
Equity 104.88 104.22 0.63 104.88 104.22 0.63 104.69 104.15 0.52
PBIDTM(%) 22.54 16.13 39.79 22.54 16.13 39.79 23.23 23.55 -1.35
24 Jul, 2024

Bliss GVS Pharma - Quaterly Results

The Sales for the quarter ended June 2024 of Rs. 1489.63 millions rose by 36.67% from Rs. 1089.92 millions.The Net Profit of the company vaulted to 159.08% to Rs. 194.21  millions from Rs. 74.96 millions in the previous quarter.Operating Profit saw a handsome growth to 335.83 millions from 175.78 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1489.63 1089.92 36.67 1489.63 1089.92 36.67 6054.60 5983.40 1.19
Other Income 68.41 65.27 4.81 68.41 65.27 4.81 335.01 507.66 -34.01
PBIDT 335.83 175.78 91.05 335.83 175.78 91.05 1406.68 1409.21 -0.18
Interest 11.68 13.09 -10.77 11.68 13.09 -10.77 58.06 100.56 -42.26
PBDT 324.15 162.69 99.24 324.15 162.69 99.24 937.76 1308.65 -28.34
Depreciation 62.61 53.64 16.72 62.61 53.64 16.72 235.19 151.73 55.01
PBT 261.54 109.05 139.83 261.54 109.05 139.83 702.57 1156.92 -39.27
TAX 67.33 34.09 97.51 67.33 34.09 97.51 196.13 302.14 -35.09
Deferred Tax -2.95 7.00 -142.14 -2.95 7.00 -142.14 -75.49 -42.10 79.31
PAT 194.21 74.96 159.08 194.21 74.96 159.08 506.44 854.78 -40.75
Equity 104.88 104.22 0.63 104.88 104.22 0.63 104.69 104.15 0.52
PBIDTM(%) 22.54 16.13 39.79 22.54 16.13 39.79 23.23 23.55 -1.35
24 Jul, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Medicamen Biotech Ltd. 572 Crore
2 Panacea Biotec Ltd. 843 Crore
3 Bajaj Healthcare Ltd. 1,017 Crore
4 Sastasundar Ventures Ltd. 993 Crore
5 Jagsonpal Pharmaceuticals Ltd. 1,041 Crore
6 Vimta Labs Ltd. 1,219 Crore
7 Bliss GVS Pharma Ltd. 1,245 Crore
8 Kopran Ltd. 1,250 Crore
9 Lincoln Pharmaceuticals Ltd. 1,306 Crore
10 KMC Speciality Hospitals (India) Ltd. 1,371 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 6,691 15,409 31.15 14.22 19.79 51.69
Abbott India Ltd. (M) Very Good 28,702 60,854 50.66 16.63 34.51 34.87
Torrent Pharmaceuticals Ltd. (L) Very Good 3,191 1,08,006 62.25 14.77 31.48 24.28
Dr. Reddys Laboratories Ltd. (L) Very Good 6,892 1,14,982 20.61 4.09 13.06 21.33
Mankind Pharma Ltd. (M) Very Good 2,065 85,892 47.11 8.94 32.84 20.88

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,840 83,886 95.37
Zydus Lifesciences Ltd. (L) Very Good 1,210 1,21,377 93.79
Granules India Ltd. (S) Somewhat Good 565.2 13,656 82.94
Glenmark Pharmaceuticals Ltd. (M) Somewhat Good 1,438 40,501 77.94
Aurobindo Pharma Ltd. (M) Very Good 1,386 81,229 75.74
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Mankind Pharma Ltd. (M) Very Good 2,065 85,892 47.11 8.94 32.84 19.33
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,888 29,269 53.87 10.14 32.32 18.11
Gland Pharma Ltd. (M) Very Good 2,020 33,015 31.64 3.67 19.94 17.42
Laurus Labs Ltd. (S) Very Good 448.8 23,316 157.3 5.70 31.81 17.07
Dr. Reddys Laboratories Ltd. (L) Very Good 6,892 1,14,982 20.61 4.09 13.06 12.64

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Lupin Ltd. (M) Somewhat Good 1,840 83,886 43.82 5.92 21.71 36.90
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,888 29,269 53.87 10.14 32.32 31.92
Biocon Ltd. (M) Somewhat Good 368.6 44,254 370.9 4.09 100.3 31.80
Mankind Pharma Ltd. (M) Very Good 2,065 85,892 47.11 8.94 32.84 29.77
Granules India Ltd. (S) Somewhat Good 565.2 13,656 31.33 4.41 17.94 24.68
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta whatsapp
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.